Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Pharmacology
|
August 8, 2012
Good penetration of moxifloxacin into human abscesses
Robert Sauermann, Rudolf Karch, Maria C Kjellsson, et al.
Frontiers in Pharmacology
|
September 6, 2021
Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria
Michael Kossmeier, Madeleine Themanns, Lena Hatapoglu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 23, 2007
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers
Julia Sacher, Nilufar Mossaheb, Christoph Spindelegger, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2005
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients
Robert Sauermann, Georg Delle-Karth, Claudia Marsik, et al.
European Journal of Clinical Pharmacology
|
September 19, 2017
Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens
Zoe Oesterreicher, Iris Minichmayr, Robert Sauermann, et al.
European Journal of Clinical Pharmacology
|
March 24, 2012
Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus
Robert Sauermann, Thomas Feurstein, Rudolf Karch, et al.
Antimicrobial Agents and Chemotherapy
|
October 28, 2005
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles
Robert Sauermann, Rudolf Karch, Herbert Langenberger, et al.
Journal of Clinical Pharmacology
|
March 29, 2014
Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection
Roza Badr Eslam, Angela Burian, Greisa Vila, et al.
Clinical and Vaccine Immunology : CVI
|
April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients
Maikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Frontiers in Pharmacology
|
October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Pharmacology
|
August 8, 2012
Good penetration of moxifloxacin into human abscesses
Robert Sauermann, Rudolf Karch, Maria C Kjellsson, et al.
Frontiers in Pharmacology
|
September 6, 2021
Assessing the Accuracy of Sales Forecasts Submitted by Pharmaceutical Companies Applying for Reimbursement in Austria
Michael Kossmeier, Madeleine Themanns, Lena Hatapoglu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 23, 2007
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers
Julia Sacher, Nilufar Mossaheb, Christoph Spindelegger, et al.
Antimicrobial Agents and Chemotherapy
|
January 28, 2005
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients
Robert Sauermann, Georg Delle-Karth, Claudia Marsik, et al.
European Journal of Clinical Pharmacology
|
September 19, 2017
Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens
Zoe Oesterreicher, Iris Minichmayr, Robert Sauermann, et al.
European Journal of Clinical Pharmacology
|
March 24, 2012
Abscess penetration of cefpirome: concentrations and simulated pharmacokinetic profiles in pus
Robert Sauermann, Thomas Feurstein, Rudolf Karch, et al.
Antimicrobial Agents and Chemotherapy
|
October 28, 2005
Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles
Robert Sauermann, Rudolf Karch, Herbert Langenberger, et al.
Journal of Clinical Pharmacology
|
March 29, 2014
Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection
Roza Badr Eslam, Angela Burian, Greisa Vila, et al.
Clinical and Vaccine Immunology : CVI
|
April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients
Maikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Frontiers in Pharmacology
|
October 14, 2016
Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, et al.
Page
of 5